publication date: Sep. 8, 2017

Funding Opportunities DOD Kidney Cancer Research Program publishes funding opportunities for FY17

The FY17 Defense Appropriations Act provides $10 million to the Department of Defense Kidney Cancer Research Program to support United States Army Medical Research Acquisition Activity.

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program Research, Development, Test, and Evaluation appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs.

The KCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY17 KCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the website in October 2017. Pre-application (Letter of Intent) and application deadlines will be available when the program announcements are released. This pre-announcement should not be construed as an obligation by the government.


Consortium Development Award

Investigators at or above Assistant Professor (or equivalent)

Supports infrastructure development to establish the necessary collaborations among a Coordinating Center and Clinical Sites

Multi-institution collaboration required

Supports clinical trials of novel interventions with the potential to have a significant impact on patient care in kidney cancer

Proposed trials may be Phase 0, Phase 1, or Phase 2

Minimum of three separate institutes: one … Continue reading DOD Kidney Cancer Research Program publishes funding opportunities for FY17

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.